Calciphylaxis and the Cardiometabolic Syndrome: The Emerging Role of Sodium Thiosulfate as a Novel Treatment Option
- 20 March 2008
- journal article
- editorial
- Published by Wiley in Journal of the CardioMetabolic Syndrome
- Vol. 3 (1) , 55-59
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Calciphylaxis: A Severe Complication of the Cardiometabolic Syndrome in Patients Receiving HemodialysisJournal of the CardioMetabolic Syndrome, 2008
- VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: Vascular Calcification—A New Window on the Cardiovascular System: Role of Agents Used to Manipulate Skeletal IntegritySeminars in Dialysis, 2007
- Nephrogenic Systemic FibrosisClinical Journal of the American Society of Nephrology, 2007
- Diabetes, kidney disease and anaemia: time to tackle a troublesome triad?International Journal Of Clinical Practice, 2007
- Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammationThe FASEB Journal, 2006
- Successful management of critical limb ischemia with intravenous sodium thiosulfate in a chronic hemodialysis patientClinical Nephrology, 2006
- Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failureNephrology Dialysis Transplantation, 2004
- Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapyKidney International, 2002
- Calcified subcutaneous arterioles with infarcts of the subcutis and skin (“calciphylaxis”) in chronic renal failureAmerican Journal of Kidney Diseases, 2000
- Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failureArchives of internal medicine (1960), 1976